PEAK6 Group’s Insys Therapeutics INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-17,850
Closed -$108K – 5278
2018
Q1
$108K Buy
+17,850
New +$147K ﹤0.01% 3680

Other funds holding INSY

PEAK6 Group's INSY Position: Q2 2018 in Review

PEAK6 Group sold out of Insys Therapeutics (INSY) in Q2 2018, closing a stake of 17,850 shares — an estimated $108K sold.

PEAK6 Group first reported a position in INSY in Q1 2018 and held it in 1 quarter. The position peaked at $108K in Q1 2018. 103 funds tracked by Wall St. Rank hold INSY as of Q2 2018.

  • PEAK6 Group reported no remaining Insys Therapeutics position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 17,850 Insys Therapeutics shares in Q2 2018, an estimated $108K.
  • PEAK6 Group first reported a position in Insys Therapeutics in Q1 2018 and held it in 1 quarter.
  • PEAK6 Group's Insys Therapeutics position peaked at $108K in Q1 2018.
  • 103 funds tracked by Wall St. Rank held Insys Therapeutics as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.